11-Mar-2013 - The European Commission (EC) says timelines for new laws requiring that risky drugs are marked for extra safety monitoring take industry practicalities into account.
20-Feb-2013 - Royal DSM expects its pharma unit to perform better in 2013 driven by a generics and end-of-lifecycle drug-focused partnership strategy.
14-Feb-2013 - AMRI has teamed up with biocatalysis firm Codexis to develop cheaper, faster and greener ways of manufacturing APIs.
11-Feb-2013 - Teva says the offloading of its Californian manufacturing facility is part of cost-cutting plans designed to save $2bn (€1.5bn). in the next few years.
30-Jan-2013 - Pfizer's CEO has raised the possibility of more cost cutting in manufacturing operations in 2013 to offset the impact of patent loss for key products.
05-Nov-2012 - Eli Lilly plans to boost its in-house insulin production capabilities will a $140m investment for its Indianapolis site.
18-Oct-2012 - Using the same equipment from R&D to scale up will cut costs, time and improve efficiency, according to GSK.
21-Aug-2012 - Regulatory professionals’ pay packets are going up despite a general industry preference for cost cutting, according to a new report by RAPS.
20-Jun-2012 - New 'similar biologics' guidelines will curb the rising cost of innovation, attract overseas investment and ensure patients have access to drugs according to the Indian Government team which launched them...
14-Jun-2012 - Biogen Idec expects the market for injectable MS drugs to shrink as patients choose more convenient delivery forms.
13-Jun-2012 - Eli Lilly will use its drug delivery device capabilities to boost the competitiveness of its developmental basal insulins, the firm’s SVP said.
12-Jun-2012 - The CEO of Lycotec says its chocolate formulation of a liver-targeted oral compound has attracted interest from the NIH and FDA.
11-Jun-2012 - The upcoming tender for antiretroviral meds (ARVs) in South Africa will be opened up to more companies in a bid to tackle shortages, an insider told us.
07-Jun-2012 - in-PharmaTechnologist.com presents a roundup of drug delivery news, including a FDA set back at Amylin and expansion at Particle Sciences.
04-Jun-2012 - AptarGroup is buying Stelmi for €165m ($205m) to expand into primary packaging components for injectable delivery devices.
28-May-2012 - West Pharmaceutical Services expects significant growth from biosimilars as manufacturers use novel delivery devices as a “key differentiator”.
15-May-2012 - Codexis posted a jump in pharma sales after the Lipitor patent loss drove an uptick in demand for its atorvastatin intermediate.
07-May-2012 - The need for novel delivery technologies is greater than ever as firms scramble to extract maximum value from drugs, an Interphex speaker said.
21-Mar-2012 - Formac Pharmaceuticals and WR Grace say their silica platform can improve the formulation selection process for poorly soluble APIs (active pharmaceutical ingredients).
13-Mar-2012 - Acuros is seeking development partnerships with Big Pharma over its recently launched water-powered drug delivery pump.
13-Feb-2012 - The FDA has said biosimilars can use different drug delivery devices than their reference products in its long-awaited guidance.
06-Dec-2011 - Samsung will set up a $300m biosimilars development JV with Massachusetts, US-based Biogen Idec, building on the partnership it forged with CRO Quintiles earlier this year.
19-Oct-2011 - Hospira says ‘quality actions’ taken to fix problems at key injectable drug manufacturing plant in US reduced its third quarter earnings.
10-Oct-2011 - iBio is expanding use of its green plant technology to biosimilar mAbs after producing rituximab using the system.
06-Oct-2011 - South Korean drugmaker Dong-A and Japan’s Meiji Seika Pharma will build a biosimilars plant in a bid to target the global Ab-based drug market.